Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$772M |
| 2 |
Eli Lilly
LLY
|
+$337M |
| 3 |
lululemon athletica
LULU
|
+$301M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$297M |
| 5 |
ResMed
RMD
|
+$273M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$576M |
| 2 |
AT&T
T
|
+$476M |
| 3 |
PNC Financial Services
PNC
|
+$393M |
| 4 |
Fortive
FTV
|
+$389M |
| 5 |
Accenture
ACN
|
+$374M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 2.82% |
| 2 | Technology | 2.79% |
| 3 | Financials | 2.26% |
| 4 | Consumer Discretionary | 1.92% |
| 5 | Industrials | 1.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
501
CALL
Biogen
BIIB
$31.2B
| $113M | 0.03% |
554,700
-72,400
| -12% | -$14.8M |
|
502
Elastic
ESTC
$8.97B
| $113M | 0.03% |
1,669,087
+1,117,849
| +203% | +$81.4M |
|
503
iShares Core MSCI EAFE ETF
IEFA
$196B
| $113M | 0.03% |
1,918,259
+1,897,171
| +8,996% | +$122M |
|
504
PUT
State Street SPDR S&P Retail ETF
XRT
$643M
| $113M | 0.03% |
1,940,100
+707,600
| +57% | +$48.2M |
|
505
Enphase Energy
ENPH
$5.39B
| $112M | 0.03% |
575,457
+239,245
| +71% | +$43.2M |
|
506
CALL
KLA
KLAC
$274B
| $112M | 0.03% |
3,521,000
+2,110,000
| +150% | +$70.9M |
|
507
PUT
Constellation Brands
STZ
$23.3B
| $112M | 0.03% |
481,100
+221,200
| +85% | +$53.8M |
|
508
Raymond James Financial
RJF
$34.8B
| $112M | 0.03% |
1,251,837
+521,889
| +71% | +$51.1M |
|
509
Costco
COST
$427B
| $112M | 0.03% |
233,491
-263,355
| -53% | -$134M |
|
510
MGM Resorts International
MGM
$11.1B
| $112M | 0.03% |
3,851,459
-861,340
| -18% | -$30.9M |
|
511
Zoetis
ZTS
$31.3B
| $111M | 0.03% |
647,258
+164,328
| +34% | +$28.4M |
|
|
XYZ
512
Block Inc
XYZ
$50B
| $111M | 0.03% |
1,805,665
+1,061,728
| +143% | +$97M |
|
513
PUT
Devon Energy
DVN
$48.9B
| $111M | 0.03% |
2,013,100
+693,600
| +53% | +$45.3M |
|
514
Jazz Pharmaceuticals
JAZZ
$15.9B
| $110M | 0.03% |
707,226
+176,935
| +33% | +$27.2M |
|
515
PUT
GDS Holdings
GDS
$6.96B
| $110M | 0.03% |
3,292,600
-145,100
| -4% | -$4.5M |
|
516
CALL
MetLife
MET
$61.9B
| $110M | 0.03% |
1,750,600
+388,900
| +29% | +$25.7M |
|
517
CALL
State Street Industrial Select Sector SPDR ETF
XLI
$34.7B
| $110M | 0.03% |
1,256,900
+321,400
| +34% | +$30.3M |
|
518
CALL
Match Group
MTCH
$8.55B
| $109M | 0.03% |
1,565,500
+351,600
| +29% | +$28.5M |
|
519
PUT
KraneShares CSI China Internet ETF
KWEB
$5.32B
| $109M | 0.03% |
3,324,400
-911,800
| -22% | -$26.2M |
|
|
520
CALL
KraneShares CSI China Internet ETF
KWEB
$5.32B
| $109M | 0.03% |
3,318,800
-1,634,900
| -33% | -$47M |
|
521
CALL
NCR Voyix
VYX
$1.17B
| $109M | 0.03% |
5,688,048
+4,844,034
| +574% | +$103M |
|
522
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
$3.69B
| $108M | 0.03% |
906,910
+372,539
| +70% | +$52.3M |
|
523
GlobalFoundries
GFS
$28.9B
| $108M | 0.03% |
2,672,999
+2,623,673
| +5,319% | +$139M |
|
524
PUT
Capital One
COF
$137B
| $107M | 0.03% |
1,031,200
+167,400
| +19% | +$20.5M |
|
525
PUT
Humana
HUM
$46.2B
| $107M | 0.03% |
229,500
+13,400
| +6% | +$5.96M |
|
Similar funds
Ken Griffin's Q2 2022 Portfolio in Review
As of Q2 2022, Ken Griffin held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Ken Griffin's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.
By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.
- Ken Griffin's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
- Ken Griffin added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
- Ken Griffin's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
- Ken Griffin fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
- Ken Griffin's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
- Ken Griffin opened 1,520 new positions and closed 2,191 in Q2 2022.
- Ken Griffin's portfolio value fell 20% quarter-over-quarter to $390B.
Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.